Extra Super Zhewitra is a combination drug containing vardenafil (40 mg) and dapoxetine (60 mg). Vardenafil is a phosphodiesterase‑5 (PDE‑5) inhibitor that helps with erectile dysfunction (ED) by increasing blood flow. However, there is no strong, peer-reviewed, controlled clinical trial data publicly available that specifically measures the efficacy of Extra Super Zhewitra (the combination) in diabetic patients, in terms of both erectile function outcomes and safety in the context of diabetes. Most of the published information relates to its general use for ED and premature ejaculation, not its performance in diabetics.